首页 > 抗体蛋白 > 抗体
PE anti-mouse CD62L Antibody
产品名称:
PE anti-mouse CD62L Antibody
产品类别:
抗体
产品编号:
104407
产品应用:
104407
[价格]
规格 价格 库存
50µg ¥ 1320 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C3H/eb mouse B lymphoma 38C-13
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 ?g per 106 cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation1-3, complement-dependent cytotoxicity4, in vivo and in vitro blocking of adhesion1-3,5, and immunohistochemical staining of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections6. The Ultra-LEAF? purified antibody (Endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays (Cat. Nos. 104457-104462).

Application References

(PubMed link indicates BioLegend citation)
  1. Gallatin WM, et al. 1983. Nature 304:30. (IP, Block)
  2. Siegelman MH, et al. 1990. Cell 61:611. (IP, Block)
  3. Lewinsohn DM, et al. 1987. J. Immunol. 138:4313. (IP, Block)
  4. Iwabuchi K, et al. 1991. Immunobiology 182:161. (CMCD)
  5. Pizcueta P, et al. 1994. Am. J. Pathol. 145:461.
  6. Reichert RA, et al. 1986. J. Immunol. 136:3535. (IHC, FC)
  7. Olver S, et al. 2006. Cancer Res. 66:571.
  8. Fukushima A, et al. 2006. Invest. Ophthalmol. Vis. Sci. 47:657. PubMed
  9. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  10. Chappaz S, et al. 2007. Blood doi:10.1182/blood-2007-02-074245. (FC) PubMed
  11. Lee JW, et al. 2006. Nature Immunol. 8:181.
  12. Shigeta A, et al. 2008. Blood 112:4915 (FC) PubMed
  13. de Vries VC, et al. 2009. Am. J. Transplant. 9:2270 PubMed
Product Citations
  1. Chen N, et al. 2021. Front Immunol. 12:756423. PubMed
  2. Pani F, et al. 2021. Endocrinology. 162:. PubMed
  3. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  4. Soon MSF, et al. 2020. Nat Immunol. 1.984027778. PubMed
  5. Laura C Burzynski et al. 2019. Immunity. 50(4):1033-1042 . PubMed
  6. Dong MB, et al. 2020. Cell. 178(5):1189-1204.e23.. PubMed
  7. Song Y, et al. 2020. Front Immunol. 11:558143. PubMed
  8. Yu Y, et al. 2022. iScience. 25:105004. PubMed
  9. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 5:64. PubMed
  10. Yang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  11. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  12. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  13. Sawada J, et al. 2021. Am J Pathol. 191:396. PubMed
  14. MacDonald K, et al. 2014. J Immunol. 192:3180. PubMed
  15. Ren S, et al. 2019. Oncol Rep. 41:1509. PubMed
  16. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  17. Hamasato E, et al. 2014. Brain Behav Immun. 11:109. PubMed
  18. Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
  19. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  20. García Nores GD, et al. 2018. Nat Commun. 9:1970. PubMed
  21. Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
  22. Ontiveros-Padilla L, et al. 2021. Microorganisms. 9:. PubMed
  23. Stewart JM, et al. 2020. ACS Biomater Sci Eng. 6:5941. PubMed
  24. Hojo MA, et al. 2019. Nat Commun. 2.224305556. PubMed
  25. Hiramoto T, et al. 2018. Mol Ther. 26:1255. PubMed
  26. Imani J, et al. 2021. JCI Insight. 6:. PubMed
  27. Wang J, et al. 2021. Nat Commun. 12:6198. PubMed
  28. Lu X, et al. 2020. Sci Transl Med. 12:. PubMed
  29. Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed
  30. Ng SS, et al. 2020. Nat Immunol. 21:1205. PubMed
  31. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  32. Green WD, et al. 2022. J Leukoc Biol. 111:147. PubMed
  33. Coquery C, et al. 2014. PLoS One. 9:102284. PubMed
  34. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  35. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  36. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  37. Kyburz A, et al. 2019. J Allergy Clin Immunol. 143:1496. PubMed
  38. Sendler M, et al. 2020. Gastroenterology. 158:253. PubMed
  39. Simula L et al. 2018. Cell reports. 25(11):3059-3073 . PubMed
  40. Zhu X et al. 2019. Cell reports. 27(4):1205-1220 . PubMed
  41. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  42. Ma X, et al. 2020. Immunity. 53:1315. PubMed
  43. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  44. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  45. Kretschmer L, et al. 2020. Nat Commun. 0.536805556. PubMed
  46. Robertson TF, et al. 2021. J Cell Biol. 220:. PubMed
  47. Gladow N, et al. 2020. PLoS One. 15:e0227734. PubMed
  48. Zheng B, et al. 2021. Bioact Mater. 6:3879. PubMed
  49. Li M, et al. 2021. Br J Pharmacol. 178:2617. PubMed
  50. Fernández-Orth J, et al. 2020. Eur J Immunol. . PubMed
  51. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  52. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  53. Sun Y, et al. 2020. J Immunol. 205:2649. PubMed
  54. Rui J, et al. 2021. Nat Commun. 12:5074. PubMed
  55. Xu Y, et al. 2021. iScience. 24:103445. PubMed
  56. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 0.252777778. PubMed
  57. Charlton J, et al. 2015. PLoS One. 10:119200. PubMed
  58. Ramanan D, et al. 2020. Cell. 181(6):1276-1290. PubMed
  59. Lee MC, et al. 2017. J Immunol. 198:3565. PubMed
  60. Lu Y, et al. 2018. Cancer Cell. 33:1048. PubMed
  61. Deptuch T, et al. 2022. Sci Rep. 12:13480. PubMed
  62. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  63. Corrado M, et al. 2020. Cell Metab. 32:981. PubMed
  64. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  65. Geng S, et al. 2019. Sci Adv. 5:eaav2309. PubMed
  66. Bantug GR, et al. 2018. Immunity. 48:542. PubMed
  67. Cao Y, et al. 2022. Small. 18:e2203466. PubMed
  68. Liu Y, et al. 2021. Nat Commun. 12:6831. PubMed
  69. Guo S, et al. 2021. Frontiers in Immunology. 11:614667. PubMed
  70. Olguín J, et al. 2015. Microbes Infect. 17: 586-595. PubMed
RRID
AB_313094 (BioLegend Cat. No. 104407) AB_313095 (BioLegend Cat. No. 104408)

Antigen Details

Structure
Selectin, 95 kD (neutrophils) or 74 kD (lymphocytes)
Distribution

Subsets of B and T cells, monocytes, granulocytes, subset of NK cells

Function
Lymphocyte homing to HEV, rolling on activated endothelium
Ligand/Receptor
CD34, GlyCAM-1, MAdCAM-1
Cell Type
B cells, Granulocytes, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Kishimoto TK, et al. 1990. P. Natl. Acad. Sci. USA 87:2244.
3. Tedder TF, et al. 1995. J. Exp. Med. 181:2259.

Gene ID
20343 View all products for this Gene ID
UniProt
View information about CD62L on UniProt.org

联系我们

TEL:021-34661275  点击拨打热线